Edit |   |
---|---|
Antigenic Specificity | MIF, Human (Imalumab biosimilar) |
Clone | Imalumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP, IHC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human MIF Recombinant Antibody. Imalumab (BAX69) is an experimental monoclonal antibody against macrophage inhibitory factor (MIF), a cytokine known to exacerbate tumor growth. and as of January 2017 it is being tested in Phase IIa clinical trials for metastatic colorectal cancer. It was developed by Cytokine PharmaSciences and Baxalta, which was purchased by Shire Pharmaceuticals. |
Immunogen | n/a |
Other Names | Anti-MIF Recombinant Antibody, Research Grade Imalumab, Anti-Human MIF Recombinant Antibody, BAX069, BAX69, Antibody Drug Analogues, Monoclonal Antibody, YR1345, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1430205-07-4 |
Catalog # | YR1345 |
Price | please inquire |
Order / More Info | MIF, Human (Imalumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |